The new-age knowledge sharing platform Technology Innovators chose BioVariance GmbH as one of the Top 20 most innovative Healthcare Technology Companies 2019.
BioVariance GmbH is one of the most innovative companies of the year 2019 for the third time in a row. (Source: brand eins Thema Innovation ist…)
BioVariance GmbH wins two new investors: FlemingEnterprise Holding GmbH (Nuremberg) and Blaugold Investment GmbH (Munich). The admission of the new investors is accompanied by the commencing cooperation with Oberender AG, a management consulting company (Bayreuth/Munich).
BioVariance GmbH won the 1st place in Senetics Innovation Award in the category “in the category “Most innovative product idea or patent in healthcare”.
The business magazine “brand eins Wissen” and Statista chose BioVariance GmbH as one of the most innovative companies in Germany.
(Source: brand eins Thema Innovation)
“Examined by brand eins Wissen und Statista, recommended by company and industry experts: The BioVariance GmbH is one of the most innovative companies in Germany.”
(Sourcee: brand eins Thema Innovation)
Smart Syringe won the 3rd place in the Open Innovation competition by Medical Valley, and also the 3rd place in Senetics Innovation Award in Healthcare.
Meeting with the Dutch royal couple of His Majesty King Willem-Alexander and Her Majesty Queen Máxima in the Medical Valley EMN in Nuremberg. Companies of Medical Valley and Dutch hightech companies discussed topics like medical robitics, diagnostics and e-health.
Development of the “Off-Label-Application – Database for child and adolescent medicine” (Medicall) in cooperation with the Julius-Maximilians-University Würzburg.
- 5 employees
- Formation of BioVariance GmbH and move to the new startup center in Waldsassen.